Bausch Health Companies Inc.

PharmaceuticalsFounded 1994

Market Data Current As Of: September 12, 2026

Related Competitor Intelligence

Compare market positioning with top industry peers

Competitor

Explore Bausch Health Companies

Core profile pages, annual revenue records, and related research hubs for this company.

Bausch Health Companies Inc.

PharmaceuticalsFounded 1994

Reviewed by Swet Parvadiya

Last reviewed: September 12, 2026

Market Data Current As Of: September 12, 2026

Financial Performance

Bausch Health Companies Revenue & Financials

Name: Bausch Health Companies Inc. Annual Revenue History
Creator: CorpDigest
License: https://corpdigest.com/terms

Revenue

$10.3B

Market Cap

$3.1B

Net Income

$157M

Employees

19,900

Financial Analysis

Bausch Health Companies continues to battle the crushing legacy debt burden inherited from the disastrous Valeant Pharmaceuticals era. Under CEO Thomas J. Appio, the firm generated exactly $8.7 billion in revenue but trades at a heavily depressed $3.1 billion market cap with exactly 19900 employees. The financial narrative in 2026 is dominated by a high-stakes legal and structural chess game; the company is attempting to fully spin off its crown jewel—the lucrative and separate Bausch + Lomb eye-care division—to satisfy its impatient creditors. Simultaneously, the core pharmaceutical business is fighting aggressive, existential legal battles to defend the patent exclusivity of its blockbuster gastrointestinal drug, Xifaxan, from generic challengers.

Revenue Trend Analysis

YoY Change

+6.7%

3-Year CAGR

+8.1%

Peak Year

2025

Trend

Consistent Growth

Bausch Health Companies Inc. has reported revenue across 4 fiscal years, compounding at +8.1% annually over 3 years. The most recent year saw a 6.7% increase versus the prior year. Revenue peaked in 2025 at $10.3B. Out of 3 reported periods, 3 showed growth and 0 showed a decline.

Annual Revenue History

Fiscal Year	Revenue	Net Income	YoY Change
FY2025	$10.3B	$157M	+6.7%
FY2024	$9.6B	—	+9.9%
FY2023	$8.8B	—	+7.8%
FY2022	$8.1B	—	—

Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.

Click any row to see year details.

Related Companies

Eli Lilly and Company Novartis AG Novo Nordisk A/S

Compare Bausch Health Companies Inc. Revenue With Competitors

Bausch Health Companies Inc. vs Eli Lilly and Company →Bausch Health Companies Inc. vs Novartis AG →Bausch Health Companies Inc. vs Novo Nordisk A/S →

Bausch Health Companies Revenue and Financial FAQ

What was Bausch Health Companies Inc.'s reported annual revenue for FY2025?

Bausch Health Companies Inc. reported approximately $8.7B in fiscal year 2025 with a team of 19,900 employees worldwide.

How does Bausch Health Companies Inc. allocate capital and manage operating margins?

Bausch Health Companies Inc. strategically balances reinvestment into core R&D with operational cost discipline, focusing on workflow automation to expand operating margins in 2026.

What is the long-term financial outlook for Bausch Health Companies Inc. in Pharmaceuticals?

Financial performance in Pharmaceuticals is driven by steady cash generation and pricing power, enabling Bausch Health Companies Inc. to reinvest in high-return strategic initiatives.

Cite or embed this data

Using these figures? Please credit CorpDigest with a link.

Cite this page

CorpDigest. "Bausch Health Companies Inc. Revenue & Financials." CorpDigest, https://corpdigest.com/company/bausch-health/financials.

Embed this data

<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>Bausch Health Companies Inc. reported $10B in revenue (FY2025).</strong><br>Source: <a href="https://corpdigest.com/company/bausch-health/financials" target="_blank" rel="noopener">CorpDigest — Bausch Health Companies Inc. financials</a></div>

Related Competitor Intelligence

Compare market positioning with top industry peers

Competitor

Eli Lilly and Company

View Competitor Intelligence

Competitor

Novartis AG

View Competitor Intelligence

Competitor

Novo Nordisk A/S

View Competitor Intelligence

Competitor

Johnson And Johnson

View Competitor Intelligence

Competitor

Pfizer

View Competitor Intelligence

Competitor

Abbvie

View Competitor Intelligence

Explore Bausch Health Companies

Core profile pages, annual revenue records, and related research hubs for this company.

Financial Analysis

Fiscal Year

Revenue

Net Income

YoY Change

FY2025

$10.3B

$157M

+6.7%

FY2024

$9.6B

—

+9.9%

FY2023

$8.8B

—

+7.8%

FY2022

$8.1B

—

Bausch Health Companies Revenue and Financial FAQ

What was Bausch Health Companies Inc.'s reported annual revenue for FY2025?

Bausch Health Companies Inc. reported approximately $8.7B in fiscal year 2025 with a team of 19,900 employees worldwide.

How does Bausch Health Companies Inc. allocate capital and manage operating margins?

Bausch Health Companies Inc. strategically balances reinvestment into core R&D with operational cost discipline, focusing on workflow automation to expand operating margins in 2026.

What is the long-term financial outlook for Bausch Health Companies Inc. in Pharmaceuticals?

Financial performance in Pharmaceuticals is driven by steady cash generation and pricing power, enabling Bausch Health Companies Inc. to reinvest in high-return strategic initiatives.

Cite or embed this data

Using these figures? Please credit CorpDigest with a link.

Cite this page

CorpDigest. "Bausch Health Companies Inc. Revenue & Financials." CorpDigest, https://corpdigest.com/company/bausch-health/financials.

Embed this data

<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>Bausch Health Companies Inc. reported $10B in revenue (FY2025).</strong><br>Source: <a href="https://corpdigest.com/company/bausch-health/financials" target="_blank" rel="noopener">CorpDigest — Bausch Health Companies Inc. financials</a></div>